• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Updates on dyslipidemia in patients with diabetes.糖尿病患者血脂异常的最新进展。
J Diabetes Investig. 2023 Sep;14(9):1041-1044. doi: 10.1111/jdi.14042. Epub 2023 Jun 22.
2
Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.混合性血脂异常、代谢综合征、糖尿病和心血管疾病：临床意义。
Am J Cardiol. 2008 Dec 22;102(12A):5L-9L. doi: 10.1016/j.amjcard.2008.09.067.
3
[Diabetes and dyslipidemia: Why are they so closely related?].[糖尿病与血脂异常：为何它们关系如此密切？]
Vnitr Lek. 2016 Fall;62(11):908-911.
4
Easy detection of atherogenic dyslipidemia by polyacrylamide gel electrophoresis in patients with type 2 diabetes mellitus.通过聚丙烯酰胺凝胶电泳在2型糖尿病患者中轻松检测致动脉粥样硬化性血脂异常。
Clin Chim Acta. 2009 Oct;408(1-2):137-8. doi: 10.1016/j.cca.2009.07.010. Epub 2009 Jul 24.
5
The prevalence and risk factors associated with dyslipidemia in type 2 diabetic patients in the autonomous Region of Cantabria.西班牙坎塔布里亚自治区 2 型糖尿病患者血脂异常的流行情况及其相关危险因素。
Endocrinol Diabetes Nutr (Engl Ed). 2020 Feb;67(2):102-112. doi: 10.1016/j.endinu.2019.04.010. Epub 2019 Jun 21.
6
Therapy and clinical trials: management of diabetic dyslipidemia.治疗与临床试验：糖尿病血脂异常的管理
Curr Opin Lipidol. 2009 Feb;20(1):85-6. doi: 10.1097/MOL.0b013e32832210b0.
7
Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease.2 型糖尿病、血脂异常和阿尔茨海默病。
J Alzheimers Dis. 2010;20(3):711-22. doi: 10.3233/JAD-2010-100012.
8
The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus.肥胖、代谢综合征与2型糖尿病大流行：第一部分。代谢综合征和2型糖尿病患者心血管疾病风险增加及致动脉粥样硬化性血脂异常的重要性。
J Cardiometab Syndr. 2009 Spring;4(2):113-9. doi: 10.1111/j.1559-4572.2008.00044.x.
9
[CoLaus: diabetes and dyslipidemia, there is always something new!].[洛桑心血管代谢队列研究：糖尿病与血脂异常，总有新发现！]
Rev Med Suisse. 2011 Nov 2;7(315):2122, 2124-6.
10
Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome.高血压、糖尿病和代谢综合征患者的血脂异常管理。
Curr Hypertens Rep. 2016 Oct;18(10):76. doi: 10.1007/s11906-016-0683-0.

引用本文的文献

1
Association Between ERBB2 and ERBB3 Polymorphisms and Dyslipidaemia and Serum Lipid Levels in a Chinese Population.中国人群中ERBB2和ERBB3基因多态性与血脂异常及血脂水平的关联
Biochem Genet. 2025 Feb 8. doi: 10.1007/s10528-025-11048-9.
2
Early impaired insulin tolerance among Vietnamese diabetes with or without dyslipidemia.越南糖尿病患者伴或不伴血脂异常者早期胰岛素敏感性受损。
Medicine (Baltimore). 2024 Nov 1;103(44):e40212. doi: 10.1097/MD.0000000000040212.
3
The differential effects of dyslipidemia status and triglyceride-glucose index on left ventricular global function and myocardial microcirculation in diabetic individuals: a cardiac magnetic resonance study.血脂异常状态和甘油三酯-葡萄糖指数对糖尿病个体左心室整体功能和心肌微循环的差异影响：一项心脏磁共振研究。
Cardiovasc Diabetol. 2024 Sep 19;23(1):345. doi: 10.1186/s12933-024-02435-4.

本文引用的文献

1
The influence of triglycerides on small dense low-density lipoprotein cholesterol levels is attenuated in low low-density lipoprotein-cholesterol range: Implications for the negative results of the PROMINENT trial.在低 LDL-胆固醇范围内，甘油三酯对小而密 LDL 胆固醇水平的影响减弱：对 PROMINENT 试验阴性结果的影响。
J Diabetes Investig. 2023 Jul;14(7):902-906. doi: 10.1111/jdi.14013. Epub 2023 Apr 4.
2
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023.10. 心血管疾病与风险管理：2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S158-S190. doi: 10.2337/dc23-S010.
3
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.用佩马弗他酯降低甘油三酯以降低心血管风险。
N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5.
4
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial.司美格鲁肽对比德谷胰岛素对 2 型糖尿病患者肝脏脂肪含量和腹部脂肪组织的影响（SURPASS-3 MRI 研究）：SURPASS-3 研究的一项随机、开放标签、平行分组、3 期亚研究。
Lancet Diabetes Endocrinol. 2022 Jun;10(6):393-406. doi: 10.1016/S2213-8587(22)00070-5. Epub 2022 Apr 22.
5
Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes.胰高血糖素样肽-1受体激动剂和钠-葡萄糖协同转运蛋白2抑制剂与2型糖尿病患者非酒精性脂肪性肝病风险
Diabetes Care. 2022 Apr 1;45(4):819-829. doi: 10.2337/dc21-1953.
6
Non-alcoholic fatty liver disease and type 2 diabetes: An update.非酒精性脂肪性肝病与 2 型糖尿病：最新进展。
J Diabetes Investig. 2022 Jun;13(6):930-940. doi: 10.1111/jdi.13756. Epub 2022 Feb 14.
7
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.替尔泊肽与司美格鲁肽每周一次治疗 2 型糖尿病患者的疗效比较。
N Engl J Med. 2021 Aug 5;385(6):503-515. doi: 10.1056/NEJMoa2107519. Epub 2021 Jun 25.
8
Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy.糖尿病视网膜病变的流行病学、危险因素、筛查和治疗的最新进展。
J Diabetes Investig. 2021 Aug;12(8):1322-1325. doi: 10.1111/jdi.13480. Epub 2021 Jan 14.
9
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.高剂量ω-3 脂肪酸与玉米油对高心血管风险患者主要不良心血管事件的影响： STRENGTH 随机临床试验。
JAMA. 2020 Dec 8;324(22):2268-2280. doi: 10.1001/jama.2020.22258.
10
Effect of sodium-glucose co-transporter 2 inhibitors on lipid profile: A systematic review and meta-analysis of 48 randomized controlled trials.钠-葡萄糖协同转运蛋白 2 抑制剂对血脂谱的影响：48 项随机对照试验的系统评价和荟萃分析。
Pharmacol Res. 2020 Oct;160:105068. doi: 10.1016/j.phrs.2020.105068. Epub 2020 Jul 8.

Updates on dyslipidemia in patients with diabetes.

作者信息

Ide Shintaro, Maezawa Yoshiro, Yokote Koutaro

机构信息

Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Chiba University Hospital, Chiba, Japan.

Department of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.

出版信息

J Diabetes Investig. 2023 Sep;14(9):1041-1044. doi: 10.1111/jdi.14042. Epub 2023 Jun 22.

DOI:10.1111/jdi.14042
PMID:37347218
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10445203/
Abstract
摘要